Compare XOMA & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XOMA | CGC |
|---|---|---|
| Founded | 1981 | N/A |
| Country | United States | Canada |
| Employees | 14 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 471.6M | 404.3M |
| IPO Year | N/A | 2023 |
| Metric | XOMA | CGC |
|---|---|---|
| Price | $42.09 | $1.03 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $52.50 | N/A |
| AVG Volume (30 Days) | 97.0K | ★ 6.6M |
| Earning Date | 05-08-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.75 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | $24.59 | $8.27 |
| Revenue Next Year | N/A | $15.68 |
| P/E Ratio | $29.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.29 | $0.84 |
| 52 Week High | $42.81 | $2.38 |
| Indicator | XOMA | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 66.32 | 43.27 |
| Support Level | $37.00 | $0.99 |
| Resistance Level | $42.81 | $1.13 |
| Average True Range (ATR) | 0.30 | 0.06 |
| MACD | -0.20 | -0.00 |
| Stochastic Oscillator | 75.25 | 37.50 |
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.